13F HOLDINGS REPORT
Fairmount Funds Management LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001104659-23-060312
Total Value
$581.5M
Positions
16
Other Managers
0
Confidential Omitted
No
Holdings (16)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AXSOME THERAPEUTICS INC | AXSM | 2,011,647 | $124.1M | 21.34% |
| 2 | NUVALENT INC | NUVL | 2,884,492 | $75.3M | 12.94% |
| 3 | VERONA PHARMA PLC | 925050106 | 3,127,429 | $62.8M | 10.80% |
| 4 | BEIGENE LTD | BEIGF | 239,443 | $51.6M | 8.88% |
| 5 | ENLIVEN THERAPEUTICS INC | ELVN | 1,924,938 | $42.2M | 7.25% |
| 6 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,369,623 | $34.8M | 5.99% |
| 7 | COGENT BIOSCIENCES INC | COGT | 2,758,975 | $29.8M | 5.12% |
| 8 | ARGENX SE | ARGX | 73,526 | $27.4M | 4.71% |
| 9 | ASTRIA THERAPEUTICS INC | 04635X102 | 1,901,397 | $25.3M | 4.35% |
| 10 | TERNS PHARMACEUTICALS INC | TERN | 2,040,000 | $24.2M | 4.15% |
| 11 | TYRA BIOSCIENCES INC | TYRA | 1,416,998 | $22.8M | 3.92% |
| 12 | THESEUS PHARMACEUTICALS INC | 88369M101 | 1,865,671 | $16.6M | 2.85% |
| 13 | GERON CORP | GERN | 7,104,358 | $15.4M | 2.65% |
| 14 | DBV TECHNOLOGIES SA | DBVTF | 7,064,964 | $11.9M | 2.05% |
| 15 | TREVI THERAPEUTICS INC | TRVI | 5,696,515 | $10.5M | 1.81% |
| 16 | MERUS N V | N5749R100 | 374,435 | $6.9M | 1.18% |